InvestorsHub Logo
Followers 826
Posts 119467
Boards Moderated 15
Alias Born 09/05/2002

Re: DewDiligence post# 691

Monday, 02/28/2022 7:32:11 PM

Monday, February 28, 2022 7:32:11 PM

Post# of 749
Skyrizi PDUFA date for Crohn’s disease extended three months due to additional data submitted by ABBV during the BLA review:

https://finance.yahoo.com/news/abbvie-provides-regarding-skyrizi-risankizumab-211500107.html

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ABBV News